Clinical Trial Update: Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia [NA]

View source ↗

Summary

This entry reports the completion and results posting of a clinical trial evaluating the role of glucagon-like peptide-1 (GLP-1) in postprandial hypoglycemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postprandial Hypoglycemia

Snippet

Sponsor: Diva De Leon | Conditions: Postprandial Hypoglycemia | NA | Status: COMPLETED | Results posted: 2016-11-09